Protagonist Therapeutics Inc(PTGX)— 技术面状态
数据截至2026-11-02 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades -2.3% vs the 50-day and +19.2% vs the 200-day average, 13.3% below the 52-week high and +84.7% off the 52-week low. Computed from daily closes.
均线状态
- 相对20日均线-0.1%
- 相对50日均线-2.3%
- 相对200日均线+19.2%
- 52周区间低于52周高点13.3% · 高于52周低点84.7%
- 连续走势连续1个交易日下跌
- 50日均线交叉股价向下穿越50日均线(今日)
- 随机指标%K 64.7 · %D 74.2(死叉)
FAQ · from the current data · as of 2026-11-02
Quick answers
PTGX当前的Closelook信号是什么?
Pullback inside an uptrend stack — Trades -2.3% vs the 50-day and +19.2% vs the 200-day average, 13.3% below the 52-week high and +84.7% off the 52-week low. Computed from daily closes.(截至2026-11-02;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
PTGX目前是否位于50日和200日均线上方?
截至2026-11-02,Protagonist Therapeutics Inc位于50日均线下方(-2.3%),200日均线上方(+19.2%);距20日均线-0.1%。
PTGX距52周高点有多远?
截至2026-11-02,低于52周高点13.3%,高于52周低点84.7%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- UCB.BR UCB SAindustry
- ARGX argenx NV ADRindustry
- REGN Regeneron Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- MRNA Moderna Incindustry
- EXEL Exelixis Incindustry
- ARQT Arcutis Biotherapeutics Incindustry
- VRDN Viridian Therapeutics Incindustry
- XNCR Xencor Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry
- BHVN Biohaven Ltd.industry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- KYMR Kymera Therapeutics Incindustry
- SEPN Septerna, Inc. Common Stockindustry
- ADMA ADMA Biologics Incindustry
- IRON Disc Medicine Inc.industry